Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), bought 146,444 shares at $4.78 ($700K) on 2018-06-08, disclosed to the SEC on 2018-06-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.78 | 20,921 | $100K | 14.3% |
| 2 | $4.78 | 20,921 | $100K | 14.3% |
| 3 | $4.78 | 52,301 | $250K | 35.7% |
| 4 | $4.78 | 52,301 | $250K | 35.7% |
| Total | $4.78 avg | 146,444 | $700K | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |